Study offers clues to how breast implants may cause lymphoma

September 17, 2014, University of Cambridge

Breast implant. Credit: US Food and Drink Administration
(Medical Xpress)—There have been 71 known cases worldwide of a type of blood cancer called anaplastic large cell lymphoma (ALCL) that the researchers suggest were associated with the patient's breast implants. This means it is an extremely rare occurrence – for every three million breast implant procedures, the study estimates between one and six cases of ALCL. The ALCL was found to develop in patients, on average, 10 years after breast augmentation or reconstruction surgery. Studies have found no clear evidence of an increase in risk of any other type of cancer in women with breast implants.

ALCL typically appears in the , skin, lungs, liver and soft tissue. It almost only ever occurs in the breast area if the patient has had breast implants and, in these cases, the tumours always develop in the around the implant capsule. The exact reasons why implants could possibly contribute to have remained unclear, however.

Researchers, funded by the charity Leukaemia & Lymphoma Research, examined case reports from patients and analysed medical literature. The findings are published in the journal Mutation Research.

ALCL patients are normally sub-divided into two groups – those with cancer cells that express an abnormal protein called anaplastic lymphoma kinase (ALK) inside the cell and those with cancer cells without the ALK protein. While eight in 10 patients with ALK-positive lymphoma survive for five years or more, ALK-negative lymphoma patients generally need more aggressive treatment and just under half survive beyond five years.

The researchers argue that implant-related ALCL, if backed by more research, should be treated as a separate clinical entity to other types of ALCL, owing to its distinctive biological characteristics. Almost all patients diagnosed with implant-related ALCL were ALK-negative and yet most actually had a very good prognosis. Of the 49 cases where information on the patients' progress was available, there were only five reported deaths.

While some patients received chemotherapy and radiotherapy, for many women their lymphoma was put into remission simply through removal of the breast implant and surrounding tissue. This suggests that it is the body's abnormal immune response to the implant that is causing the cancer. Chemotherapy was not shown to significantly increase survival in patients.

There is some evidence to suggest that simply having a prosthetic implant can increase risk as opposed to anything connected with the breast implant material, as with hip or knee replacements may also have a very small increased chance of developing lymphoma. Others have proposed that it is differences in lifestyles of people with and without that could be responsible. The Cambridge scientists, however, argue that the biological features of lymphomas in the presence of implants, such as the lack of ALK and the proximity to the implant, suggest a real link.

Dr Suzanne Turner, who led the research at the University of Cambridge, said, "It's becoming clear that implant-related ALCL is a distinct clinical entity in itself. There are still unanswered questions and only by getting to the bottom of this very rare disease will we be able to find alternative ways to treat it."

Dr Matt Kaiser, Head of Research at Leukaemia & Lymphoma Research, said: "It's important to remember that any breast implant-associated lymphoma is incredibly rare. It is, however, important to investigate any possible links to what causes these cancers, so that we can help people balance benefits versus risks and so that we can work out how we might be able to prevent the risks altogether."

Explore further: Study confirms link between breast implants and rare form of cancer

Related Stories

Study confirms link between breast implants and rare form of cancer

April 19, 2011
Breast implants appear to be associated with a rare form of lymphoma, but there is not yet evidence to show that the cancer is caused by implants or to suggest an underlying mechanism for how the disease might develop, according ...

Before deciding on breast implants, consider FDA precautions

February 27, 2013
(HealthDay)—If you're thinking about getting breast implants, there are some things you need to know before you make your decision, according to the U.S. Food and Drug Administration.

Complication rates low with mastectomy, breast reconstruction: study

September 2, 2014
(HealthDay)—Complications are rare among breast cancer patients who undergo mastectomy and reconstruction, a new study indicates.

Of mice and men

October 15, 2012
The use of carefully chosen animal models often underlies crucial medical advances. A perfect example is provided by the recent demonstration that a known drug, imatinib, can be used to treat a rare but highly aggressive ...

20 cancer cases in French women with PIP implants: agency

December 30, 2011
French health authorities said Friday that 20 cases of cancer had been uncovered in women with allegedly faulty French-made breast implants but insisted there was still no proven link with the disease.

FDA approves new silicone breast implants

June 17, 2013
(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

Recommended for you

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

New drug discovery could halt spread of brain cancer

November 19, 2018
The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

Use genetic data to predict the best time of day to give radiotherapy to breast cancer patients, say researchers

November 19, 2018
A new clinical study led by the University of Leicester and conducted in the HOPE clinical trials facility at Leicester's Hospitals has revealed the pivotal role that changing the time of day that a patient receives radiotherapy ...

New blood test detects early stage ovarian cancer

November 19, 2018
Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer—a disease which kills over 1000 Australian women and 150,000 globally each ...

New dual-action cancer-killing virus

November 19, 2018
Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.

From the ashes of a failed pain drug, a new therapeutic path emerges

November 16, 2018
In 2013, renowned Boston Children's Hospital pain researcher Clifford Woolf, MB, BCh, Ph.D., and chemist Kai Johnsson, Ph.D., his fellow co-founder at Quartet Medicine, believed they held the key to non-narcotic pain relief. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.